2-chloroadenine has been researched along with adenine in 20 studies
*Adenine: A purine base and a fundamental unit of ADENINE NUCLEOTIDES. [MeSH]
*Adenine: A purine base and a fundamental unit of ADENINE NUCLEOTIDES. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 7 (35.00) | 29.6817 |
2010's | 5 (25.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Hanus, J; Havlícek, L; Leclerc, S; Meijer, L; Shaw, G; Strnad, M; Veselý, J | 1 |
de Koning, HP; Eze, AA; Gustavsson, AL; Hammarström, LG; Lundbäck, T; Olivera, GC; Rottenberg, ME; Sjöberg, B; Svensson, R; Vodnala, SK; Yeheskieli, E | 1 |
Carlson, EE; Goswami, M; Wilke, KE | 1 |
Bugg, BY; Grippo, P; Hentosh, P; McCastlain, JC | 1 |
Hentosh, P; McCastlain, JC | 1 |
Grippo, P; Hentosh, P; Tibudan, M | 1 |
Grippo, P; Hentosh, P | 2 |
Albertioni, F; Liliemark, J; Lindemalm, S | 1 |
Bontemps, F; Cardoen, S; Delacauw, A; Van Den Berghe, G; Van Den Neste, E | 1 |
Xie, D; Xu, D; Xue, Y; Yan, G | 1 |
Doláková, P; Holý, A; Masojídková, M | 1 |
Albertioni, F; Juliusson, G; Larsson, R; Liliemark, J; Lindemalm, S | 1 |
Ashton, KJ; Headrick, JP; Holmgren, K; Willems, L; Zatta, A | 1 |
Banach, K; Bojarska, E; Bzowska, A; Kazimierczuk, Z; Magnowska, L | 1 |
Akula, KK; Dhir, A; Kulkarni, SK | 1 |
Davis, B; Li, P; Maguma, HT; Taylor, DA; Thayne, K | 1 |
Kopyra, J; Kossoski, F; Varella, MT | 1 |
Ekblom, M; Karlsson, MO; Munafo, A; Novakovic, AM; Savic, RM | 1 |
Guo, L; Huang, Y; Li, Z; Luo, HB; Wu, XN; Wu, Y; Zheng, D; Zhou, Q | 1 |
2 trial(s) available for 2-chloroadenine and adenine
Article | Year |
---|---|
Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.
Topics: Adenine; Administration, Oral; Area Under Curve; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Tumor Cells, Cultured | 2004 |
Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis.
Topics: Adenine; Administration, Intravenous; Administration, Oral; Adult; Aged; Cladribine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Models, Biological; Multiple Sclerosis | 2017 |
18 other study(ies) available for 2-chloroadenine and adenine
Article | Year |
---|---|
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
Topics: Animals; CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Enzyme Inhibitors; Kinetin; Oocytes; Purines; Roscovitine; Starfish; Tumor Cells, Cultured | 1997 |
Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
Topics: Animals; Cell Survival; Cells, Cultured; Deoxyadenosines; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2013 |
Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.
Topics: Adenine; Adenosine Triphosphate; Anti-Bacterial Agents; Aspartic Acid; Bacteria; Drug Design; Histidine Kinase; HSP90 Heat-Shock Proteins; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship | 2017 |
Polymerase chain reaction amplification of single-stranded DNA containing a base analog, 2-chloradenine.
Topics: Adenine; Base Sequence; DNA; DNA, Single-Stranded; Molecular Sequence Data; Polymerase Chain Reaction | 1992 |
Effects of 2-chloroadenine substitution in DNA on restriction endonuclease cleavage reactions.
Topics: Adenine; Autoradiography; Base Sequence; DNA; DNA Restriction Enzymes; Electrophoresis, Polyacrylamide Gel; Molecular Sequence Data; Nucleic Acid Heteroduplexes | 1991 |
A human factor that recognizes DNA substituted with 2-chloroadenine, an antileukemic purine analog.
Topics: Adenine; Base Sequence; DNA Damage; DNA Repair; DNA-Binding Proteins; HeLa Cells; Humans; In Vitro Techniques; Molecular Sequence Data; Nuclear Proteins; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Xeroderma Pigmentosum | 1995 |
Template 2-chloro-2'-deoxyadenosine monophosphate inhibits in vitro DNA synthesis.
Topics: Adenine; Bacteriophage M13; Base Sequence; Cladribine; Deoxyribonucleotides; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Humans; Molecular Sequence Data; Templates, Genetic | 1994 |
2-Chloro-2'-deoxyadenosine monophosphate residues in DNA enhance susceptibility to 3'-->5' exonucleases.
Topics: Adenine; Base Sequence; Cladribine; DNA; DNA Nucleotidyltransferases; DNA Polymerase I; DNA Polymerase II; DNA-Directed DNA Polymerase; Escherichia coli; Exodeoxyribonucleases; Molecular Sequence Data; Molecular Weight; Viral Proteins | 1994 |
Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.
Topics: Adenine; Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Chromatography, High Pressure Liquid; Cladribine; Clofarabine; Female; Humans; Male; Middle Aged; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1997 |
Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine.
Topics: Adenine; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Nucleotides; Tritium; Tumor Cells, Cultured | 2000 |
Density functional theory studies on tautomeric stability and infrared spectra of 2-chloroadenine.
Topics: Adenine; Drug Stability; Models, Chemical; Molecular Conformation; Spectrophotometry, Infrared | 2000 |
Synthesis of base substituted 2-hydroxy-3-(purin-9-yl)-propanoic acids and 4-(purin-9-yl)-3-butenoic acids.
Topics: 2-Aminopurine; Adenine; Antineoplastic Agents; Antiviral Agents; Butyrates; Guanine; Hypoxanthines; Lactic Acid; Magnetic Resonance Spectroscopy; Molecular Structure; Purines | 2003 |
Age-related changes in ischemic tolerance in male and female mouse hearts.
Topics: Adenine; Adenosine Diphosphate; Aging; Animals; Collagen; Coronary Vessels; Female; Heart; Hydro-Lyases; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Sex Characteristics | 2005 |
Kinetic model of oxidation catalyzed by xanthine oxidase-the final enzyme in degradation of purine nucleosides and nucleotides.
Topics: Adenine; Chemical Phenomena; Chemistry; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Kinetics; Models, Theoretical; Oxygen; Purine Nucleosides; Regression Analysis; Xanthine; Xanthine Oxidase | 2005 |
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
Topics: Adenine; Adenosine; Analysis of Variance; Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Lactones; Male; Mice; Pentylenetetrazole; Seizures; Sulfones | 2008 |
Correlation of the time course of development and decay of tolerance to morphine with alterations in sodium pump protein isoform abundance.
Topics: Adenine; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Guinea Pigs; Male; Morphine; Myenteric Plexus; Protein Isoforms; Sodium-Potassium-Exchanging ATPase; Weight Gain | 2010 |
Anion states and fragmentation of 2-chloroadenine upon low-energy electron collisions.
Topics: Adenine; Anions; Electrons; Hydrogen; Quantum Theory | 2015 |
Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Administration, Oral; Animals; Behavior, Animal; Binding Sites; Crystallography, X-Ray; Dementia, Vascular; Disease Models, Animal; Drug Design; Half-Life; Humans; Inhibitory Concentration 50; Isoenzymes; Mice; Molecular Dynamics Simulation; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2020 |